Package 65197-203-09

{"route": ["ORAL"], "spl_id": "a6121b17-e850-4677-9ad1-ceb36de16336", "openfda": {"unii": ["B22547B95K"], "rxcui": ["2671573", "2671579"], "spl_set_id": ["9d8d2ee7-9db7-4be7-8c73-511eb2e32459"], "manufacturer_name": ["WellSpring Pharmaceutical Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 POWDER, FOR SOLUTION in 1 CARTON (65197-203-09)", "package_ndc": "65197-203-09", "marketing_start_date": "20231201"}], "brand_name": "Emetrol Powder Non-Drowsy", "product_id": "65197-203_a6121b17-e850-4677-9ad1-ceb36de16336", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Acidifying Activity [MoA]", "Anti-coagulant [EPC]", "Calcium Chelating Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Decreased Coagulation Factor Activity [PE]"], "product_ndc": "65197-203", "generic_name": "Sodium Citrate Dihydrate", "labeler_name": "WellSpring Pharmaceutical Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Emetrol Powder", "brand_name_suffix": "Non-Drowsy", "active_ingredients": [{"name": "TRISODIUM CITRATE DIHYDRATE", "strength": "460 mg/1"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20231201", "listing_expiration_date": "20261231"}